Join Hands to Build a Sustainable Financial Future
In these turbulent times, FBT adheres to long-termism, firmly believes in the future development of biomedicine, and continuously practices high-quality development. Over the past year, the management team has shouldered its responsibilities, adjusted strategies in a timely manner, focused on core businesses, and responded to industry cyclical changes with a cautious and pragmatic approach.
FBT is committed to close communication with shareholders and capital markets. Through a professional investor relations team, the company actively maintains contact with shareholders, institutional investors, and analysts to ensure that the market can receive the company's information quickly, equally, and in a timely manner, enabling them to effectively evaluate and make ideal investment decisions.
FBT Annual Statements – FRS 16 (1) Standard
| 2024A | 2025E | 2026E | 2027E | 2028E | |
|---|---|---|---|---|---|
| Total Revenue | 850,643 | 1,105,835 | 1,437,586 | 2,156,379 | 3,234,569 |
| Gross Margin % | 100% | 90% | 90% | 90% | 90% |
| Operating Profit | (483,886) | 208,868 | 269,659 | 404,488 | 606,732 |
| Operating Margin % | (57%) | 19% | 19% | 19% | 19% |
| EBITDA (2) | (473,319) | 331,751 | 221,167 | 431,276 | 646,914 |
| EBITDA Margin % | (56%) | 20% | 20% | 20% | 20% |
| Net Profit | (363,908) | 228,231 | 269,476 | 395,638 | 532,936 |
(1) As Hong Kong Financial Reporting Standards and International Financial Reporting Standards are fully convergent in terms of lease accounting, for ease of reference, IFRS 16 "Leases" (IFRS 16) and the former lease accounting standard IAS 17 "Leases" (IAS 17) are used interchangeably with the relevant Hong Kong Financial Reporting Standards when referenced in the results announcement. The financial information of the benchmark is reviewed periodically by management and used for resource allocation, performance evaluation and internal decision-making. Unless otherwise specified, the presentation of the Company's operating results in the results announcement is based on IFRS 16.
(2) Earning before interest, tax, depreciation and amortization (EBITDA)